Dallas Business Journal Health
6/18 6:17A
Sydney Asher
The biotech firm filed its IPO paperwork May 23 in a bid to boost its finances, noting there was "substantial doubt" about its ability to continue operating otherwise. Now the company is debuting on the Nasdaq — get the latest in this storty.